Pharmacologic Management of Persistent Pain in Cancer Survivors.

ABSTRACT: Improvements in screening, diagnosis and treatment of cancer has seen cancer mortality substantially diminish in the past three decades. It is estimated there are almost 20 million cancer survivors in the USA alone, but some 40% live with chronic pain after completing treatment. While a broad definition of survivorship that includes all people living with, through and beyond a cancer diagnosis-including those with active cancer-is often used, this narrative review primarily focuses on the management of pain in people who are disease-free after completing primary cancer treatment as adults. Chronic pain in this population needs a different approach to that used for people with a limited prognosis. After describing the common chronic pain syndromes caused by cancer treatment, and the pathoph

SUBMITTER: Glare P 

PROVIDER: S-EPMC8888381 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature